Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation.

× No keyword cloud information.

27 in total

Review 1. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

Authors: Carol E Parker; Christoph H Borchers
Journal: Mol Oncol Date: 2014-03-20 Impact factor: 6.603

2. Rac1 regulates platelet shedding of CD40L in abdominal sepsis.

Authors: Rundk Hwaiz; Milladur Rahman; Enming Zhang; Henrik Thorlacius
Journal: Lab Invest Date: 2014-07-21 Impact factor: 5.662

3. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors: Ferdinando Mannello; Joseph D Raffetto
Journal: Am J Transl Res Date: 2010-11-23 Impact factor: 4.060

Review 4. Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.

Authors: Mohit K Turagam; Mahek Mirza; Paul H Werner; Jasbir Sra; David C Kress; A Jamil Tajik; Arshad Jahangir
Journal: Cardiol Rev Date: 2016 Mar-Apr Impact factor: 2.644

5. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.

Authors: Vesna V Dragutinović; Nevena V Radonjić; Nataša D Petronijević; Svetislav B Tatić; Ivan B Dimitrijević; Nebojša S Radovanović; Zoran V Krivokapić
Journal: Mol Cell Biochem Date: 2011-05-04 Impact factor: 3.396

10. Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.

Authors: Janusz K Rybakowski
Journal: Cardiovasc Psychiatry Neurol Date: 2009-08-31

Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation.

Review 1. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

2. Rac1 regulates platelet shedding of CD40L in abdominal sepsis.

3. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Review 4. Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.

5. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.

6. Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles.

7. Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.

8. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.

Review 9. Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.

10. Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.